M. Fotis

发表

Evaluation of Hepatotoxicity with Off-Label Oral-Treatment Doses of Voriconazole for Invasive Fungal Infections

M. Postelnick, S. Trifilio, M. Scheetz, 2010, Antimicrobial Agents and Chemotherapy.

Insights from the sharp end of intravenous medication errors: implications for infusion pump technology

D. Rooney, C. Barnard, G. Noskin, 2005, Quality and Safety in Health Care.

Implementation of an Extended-Infusion Piperacillin-Tazobactam Dosing Protocol: Unexpected Findings when Monitoring Safety and Compliance with Smart Pump Technology

Sean N. Avedissian, M. Fotis, H. Brake, 2019, Pharmacy.

Completeness and effectiveness of reporting on three drugs: Lessons learned from RADAR, a novel pharmacosurveillance and pharmacovigilance program

S. Belknap, C. Bennett, J. Mckoy, 2004 .

Comparison of treatment of patients with congestive heart failure by cardiologists versus noncardiologists.

M. Fotis, J. A. Patel, 2005, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Predictors of neonatal production of IFN-g and relation to later wheeze

M. Postelnick, T. Zembower, M. Fotis, 2011 .

Pharmacist interventions to improve the management of coronary artery disease.

M. Gheorghiade, P. Yarnold, M. Fotis, 2004, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Medication use in the neonatal intensive care unit: current patterns and off-label use of parenteral medications.

Praveen Kumar, M. Fotis, K. Hurt, 2008, The Journal of pediatrics.

The incidence of antimicrobial allergies in hospitalized patients: implications regarding prescribing patterns and emerging bacterial resistance.

M. Postelnick, L. Peterson, G. Noskin, 2000, Archives of internal medicine.

Lack of effect of fluoroquinolone resistance on mortality in subjects with Pseudomonas aeruginosa bacteraemia.

M. Postelnick, M. Scheetz, M. Bolon, 2006, The Journal of infection.

Risk Evaluation and Mitigation Strategies (REMS)

M. Fotis, 2012 .

Developing a model to determine the effects of adverse drug events in hospital inpatients.

M. Fotis, E. Nilsen, 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Pharmacist participation in medical rounds reduces medication errors.

G. Noskin, Gary A Noskin, Kimberly K Scarsi, 2002, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Cancer pain management through a pharmacist-based analgesic dosing service.

J. V. Von Roenn, S. Weitzman, C. V. von Gunten, 1999, American Journal of Health-System Pharmacy.

Chapter 27, Clinical Analysis of Adverse Drug Reactions

M. Fotis, W. Budris, 2012 .

Hospitalwide adverse drug events before and after limiting weekly work hours of medical residents to 80.

M. McDaniel, J. Regalado, M. Mycyk, 2005, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Insights from the sharp end of intravenous medication errors: implications for infusion pump technology

C. Barnard, G. Noskin, M. Husch, 2005, Quality and Safety in Health Care.